VYNE Therapeutics Inc (VYNE)
2.48
+0.01
(+0.40%)
USD |
NASDAQ |
Apr 26, 16:00
2.48
0.00 (0.00%)
After-Hours: 17:32
VYNE Therapeutics Revenue (TTM): 0.424M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.424M |
| September 30, 2023 | 0.354M |
| June 30, 2023 | 0.407M |
| March 31, 2023 | 0.398M |
| December 31, 2022 | 0.477M |
| September 30, 2022 | 0.744M |
| June 30, 2022 | 0.71M |
| March 31, 2022 | 0.879M |
| December 31, 2021 | 0.931M |
| September 30, 2021 | 4.944M |
| June 30, 2021 | 8.08M |
| March 31, 2021 | 19.47M |
| December 31, 2020 | 20.99M |
| Date | Value |
|---|---|
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | 14.32M |
| March 31, 2018 | 4.63M |
| December 31, 2017 | 4.582M |
| September 30, 2017 | 2.257M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.354M
Minimum
Sep 2023
20.99M
Maximum
Dec 2020
4.524M
Average
0.744M
Median
Sep 2022
Revenue (TTM) Benchmarks
| Viking Therapeutics Inc | -- |
| AN2 Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |